Healthy Sail Panel

Healthy Sail Panel

Scroll for More#
Find a Journey

Find a Journey:

Voyages

Select a Journey Type

Voyages
Land Programs
Any Destination

Select a Destination (You can select multiple destinations)

Any Destination
Africa
Asia
Australia & New Zealand
Caribbean
Mediterranean
Northern & Western Europe
Panama Canal, Central & North America
South America
Transoceanic
 
Any Month/Year

Select a Month (You can select multiple months)

Any Month
2020
Nov
Dec
2021
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2022
Jan
Feb
Mar
Apr
Any Duration

Select a Duration

Any Duration
9 Nights or Fewer
10 to 14 Nights
15 Nights or More

Meet Our Experts

Introducing our new “Healthy Sail Panel” — a team of cross-disciplinary experts enlisted to guide the cruise industry’s way forward in response to COVID-19. Comprised of globally recognized specialists in public health, infectious diseases, hospitality and maritime operations, the panel will advise us on a science-backed plan for a healthy return to service that ensures the wellbeing of our guests and crew as well as the communities we visit.

Visit our press release here to learn more about this announcement.

Governor Mike Leavitt

Governor Mike Leavitt

Co-chair

Mike Leavitt was a three-term Governor of Utah and served as Administrator of the EPA and Secretary of HHS under President George W. Bush. He is the founder of Leavitt Partners, a firm that provides investment support, data and analytics, member-based alliances, and direct services to clients to support decision-making strategies in the value economy.

Dr. Scott Gottlieb

Dr. Scott Gottlieb

Co-chair

Dr. Scott Gottlieb was the Commissioner of the FDA from 2017-2019 and served as the agency’s Deputy Commissioner for Medical and Scientific Affairs from 2005- 2007. He is a physician trained in internal medicine and is currently a resident fellow at the American Enterprise Institute.

Helene Gayle, M.D., M.P.H.

Helene Gayle, M.D., M.P.H.

Dr. Gayle is CEO of the Chicago Community Trust. Dr. Gayle spent 20 years with the Centers for Disease Control. She worked at the Bill & Melinda Gates Foundation, directing programs pertaining to global health issues. Dr. Gayle serves on boards including The Coca-Cola Company, Colgate-Palmolive Company, Brookings Institution, the Center for Strategic and International Studies, the Federal Reserve Bank of Chicago and the Economic Club of Chicago. She is a member of the Council on Foreign Relations, the American Public Health Association, the National Academy of Medicine, the National Medical Association and the American Academy of Pediatrics.

Patrik Dahlgren

Patrik Dahlgren

Captain Dahlgren is the SVP of Global Marine Operations and Fleet Optimization for RCL. Patrik's seagoing experiences began as a bridge officer with tugboats, yachts and an array of cargo vessels and ferries. He rose through the ranks with over 15 years onboard Royal Caribbean Internationals cruise ships, with his last seagoing command as Master of Oasis of the Seas and Quantum of the Seas. He was the lead contributor to the Quantum of the Seas development, which received the esteemed RINA (Royal Institute of Naval Architects) award for its innovation and largest contribution to maritime safety.

Julie Gerberding, M.D., M.P.H.

Julie Gerberding, M.D., M.P.H.

Dr. Gerberding is EVP/Chief Patient Officer for Merck and a world-renowned public health expert. Prior to joining Merck, she served as the Director of the CDC from 2002-2009. While at the agency, she led more than 40 emergency responses against crises such as anthrax, SARS, bird flu, food-borne outbreaks and natural disasters. Previously, Dr. Gerberding was a tenured faculty member in Infectious Diseases at the University of California at San Francisco (UCSF). She continues as an Adjunct Associate Clinical Professor of Medicine at UCSF.

Steven Hinrichs, M.D.

Steven Hinrichs, M.D.

Dr. Hinrichs is Chair of the Department of Pathology and Microbiology at the University of Nebraska Medical Center, Director of the Nebraska Public Health Laboratory, and Director of the University of Nebraska Center for Biosecurity. He is principal investigator of multiple national awards from the Association of Public Health Laboratories, CDC and DoD for the development of an outreach program to extend training and expertise in the early recognition of biological warfare agents. He has published over 130 papers in basic science and medical journals.

Robin Lindsay

Robin Lindsay

Mr. Lindsay is the EVP of Vessel Operations for NCL. He was appointed to this position in January 2015. In this role, Lindsay is responsible for Marine & Technical Operations, Hotel Operations, Entertainment, Product Development, Port & Destination Services, Fleet Personnel, Out Islands and New Build & Ship Refurbishment. Lindsay served in a similar capacity as EVP of Vessel Operations at Prestige Cruise Holdings, the parent company of Oceania Cruises and Regent Seven Seas Cruises. Lindsay's history with the company goes back to the inception of Oceania Cruises in 2003, where he joined as SVP, Hotel Operations and Vessel Operations. Lindsay earned his B.S. degree from Louisiana Tech University.

Michael Osterholm, M.D., Ph.D.

Michael Osterholm, M.D., Ph.D.

Dr. Osterholm is one of the foremost experts in public health, infectious disease and biosecurity. As director of the Center for Infectious Disease Research at the University of Minnesota, he is an international leader on pandemics preparedness. He is a consultant to the WHO, NIH, FDA, DoD and CDC. From 2001 to 2005, he served as advisor to the Secretary of U.S. Health and Human Services on issues related to bioterrorism and public health preparedness. From 2018 to 2019, he served as a Science Envoy for Health Security on behalf of the US State Department. He has also been appointed to the National Science Advisory Board on Biosecurity and the World Economic Forum’s working group on pandemics.

Stephen Ostroff, M.D.

Stephen Ostroff, M.D.

Dr. Ostrofff was Acting Commissioner of the FDA from 2015 to 2016, and before that served as the FDA’s chief scientist. He joined FDA in 2013 as chief medical officer in the Center for Food Safety and Applied Nutrition and senior public health advisor to FDA’s Office of Foods and Veterinary Medicine. Prior to that he served as deputy director of the National Center for Infectious Diseases at the CDC. He retired from the Commissioned Corps of the U.S. Public Health Service at the rank of Rear Admiral (Asst. Surgeon General). He was also the director of the Bureau of Epidemiology and acting physician general of Pennsylvania.

William Rutala, Ph.D., M.S., M.P.H.

William Rutala, Ph.D., M.S., M.P.H.

Dr. Rutala has extensive experience managing a variety of diseases and studying epidemiology and virology, particularly managing outbreaks and emerging pathogens. His research interests are the etiology and prevention of healthcare-associated infections with a focus on disinfection and sterilization of reusable medical and surgical devices. Other areas of research include contribution of the hospital environment to disease transmission, hand hygiene, preventing transmission of infectious agents, including multiply-drug resistant organisms, prevention of healthcare-associated Creutzfeldt-Jacob Disease, investigation of healthcare-associated outbreaks, and new and emerging pathogens.

Kate Walsh

Kate Walsh

Ms. Walsh is the Dean at the School of Hotel Administration at Cornell University; a leader in education for the global hospitality industry; and a renowned expert in organizational service design, leadership and career development, and the strategic investments of human capital. She has over twenty years of academic experience, including in her current role, where she is responsible for a $100M enterprise to prepare tech-savvy and people-focused leaders, and conducts impactful research to address pressing industry issues She is a former certified public accountant and industry executive in human resources.

Choose Azamara®

For Your Next Voyage

Talk to an expert

1-833-292-2292

X